The influence of Visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis
2019
Introduction
The impact of the two adipokines, visfatin and retinol-binding protein 4 (RBP-4) on bone mineral density (BMD) has been analysed in various studies with conflicting results. Visfatin is highly expressed in visceral fat with stimulatory effect on osteoblast proliferation and inhibition on osteoclast formation, while RBP-4 acts as a transporter protein for retinol, associated with changes in insulin sensitivity, independent of obesity, with no consensus on its effect on bone metabolism. We evaluated the relationship between serum concentrations of visfatin, RBP-4, markers of insulin resistance and current BMD in treated postmenopausal osteoporosis (PO).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
3
Citations
NaN
KQI